Yifeng Sun
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Oncology
- Cardiology and Cardiovascular Medicine
- Pathology and Forensic Medicine
- Topics
- Esophageal Cancer Research and Treatment (20 papers)Gastric Cancer Management and Outcomes (16 papers)Esophageal and GI Pathology (15 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yifeng Sun
40 papers receiving 700 citations
Hit Papers
Peers
Comparison fields: 5 of 54
- Surgery 566
- Pulmonary and Respiratory Medicine 403
- Oncology 163
- Cardiology and Cardiovascular Medicine 139
- Pathology and Forensic Medicine 40
Countries citing papers authored by Yifeng Sun
This map shows the geographic impact of Yifeng Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifeng Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifeng Sun more than expected).
Fields of papers citing papers by Yifeng Sun
This network shows the impact of papers produced by Yifeng Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifeng Sun. The network helps show where Yifeng Sun may publish in the future.
Co-authorship network of co-authors of Yifeng Sun
This figure shows the co-authorship network connecting the top 25 collaborators of Yifeng Sun. A scholar is included among the top collaborators of Yifeng Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifeng Sun. Yifeng Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinomabreakdown → | 161 |
| 6 | 8 | |
| 7 | 24 | |
| 8 | 6 | |
| 9 | 4 | |
| 10 | 7 | |
| 11 | 5 | |
| 12 | 6 | |
| 13 | 17 | |
| 14 | 25 | |
| 15 | 5 | |
| 16 | 10 | |
| 17 | 12 | |
| 18 | 8 | |
| 19 | 12 | |
| 20 | 3 |
About Yifeng Sun
Yifeng Sun is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Surgery, having authored 42 papers that have together received 705 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (20 papers), Gastric Cancer Management and Outcomes (16 papers) and Esophageal and GI Pathology (15 papers). The work is most often cited by research in Surgery (566 citations), Pulmonary and Respiratory Medicine (403 citations) and Cardiology and Cardiovascular Medicine (139 citations). Yifeng Sun has collaborated with scholars based in China, United States and France. Frequent co-authors include Zhigang Li, Hezhong Chen, Xufeng Guo, Rong Hua, Bentong Yu, Yunqing Mei, Xisheng Wang, Qiang Ji, Liangjie Chi and Jing Feng. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.